Skip to main content
Log in

Characterization of protease production by a type-III group-BStreptococcus

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

A type-III group-B streptococcus (Streptococcus agalactiae) isolated from a case of late-onset sepsis was examined for protease production. In broth culture, extracellular proteolytic enzymes were not detected until the late exponential phase of growth with maximal protease production occurring during the stationary phase. Three distinct protease pools were isolated from the supernatant fluids of stationary-phase cultures, employing a combination of ion-exchange chromatography and gel-filtration chromatography. One population of proteases (containing two protease pools separable by gel filtration chromatography) eluted from a diethylaminoethyl cellulose column at a sodium chloride gradient concentration of 0.15M while a second population eluted from the same material at a sodium chloride concentration of 0.35M. These protease pools varied in molecular weights from approximately 25,000 daltons to 160,000 daltons as determined by gel filtration on Sephadex G-200. All three protease preparations had pH optima of 8.0–9.0, and all were active against gelatin, human serum albumin, and casein, but were not active against elastin or collagen. In addition, all three protease preparations completely inactivated purified type-III group-B streptococal neuraminidase. The role of these proteases in the disease process caused by the type-III group-B streptococci must remain speculative at this time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. Aminoff D (1961) Methods for quantitative estimation ofN-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J 81:384–392

    PubMed  Google Scholar 

  2. Baker CJ (1977) Summary of the workshop on perinatal infections due to group BStreptococcus. J Infect Dis 136:137–152

    PubMed  Google Scholar 

  3. Davis BJ (1964) Disc electrophoresis. II. Method and application to human serum proteins. Ann NY Acad Sci 121:404–424

    PubMed  Google Scholar 

  4. Deibel RH (1963) Hydrolysis of proteins and nucleic acids by Lancefield group A and other streptococci. J Bacteriol 86:1270–1274

    PubMed  Google Scholar 

  5. Doran TI, Straus DC, Mattingly SJ (1980) Extracellular antigens of serotype III group B streptococci. Infect Immun 30:890–893

    PubMed  Google Scholar 

  6. Durham DL, Mattingly SJ, Doran TI, Milligan TW, Straus DC (1981) Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infect Immun 34:448–454

    PubMed  Google Scholar 

  7. Durham DL, Straus DC (1983) Extracellular products of type IIIStreptococcus agalactiae and their relationship to virulence. Curr Microbiol 8:89–94

    Google Scholar 

  8. Elliot SD (1945) A proteolytic enzyme produced by group A streptococci with special reference to its effect on the type specific M-antigen. J Exp Med 81:573–592

    Google Scholar 

  9. Ferrier P, Gray ED, Wannamaker LH (1980) Biochemical and immunological characterization of the extracellular nucleases of group B streptococci. J Exp Med 151:56–68

    PubMed  Google Scholar 

  10. Hellerqvist CG, Rojas J, Green RS, Sell S, Sundell H, Stahlman MT (1981) Studies on group B β-hemolytic streptococcus. I. Isolation and partial characterization of an extracellular toxin. Pediatr Res 15:892–898

    PubMed  Google Scholar 

  11. Kjems E, Perch B, Henrichsen J (1980) Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin. J Clin Microbiol 11:111–113

    PubMed  Google Scholar 

  12. Knight CG (1977) Principles of the design and use of synthetic substrates and inhibitors for tissue proteinase. 3 Design and use of synthetic inhibitors. In: Barrett AJ (ed) Proteinase in mammalian cells and tissues. Amsterdam: Elsevier/North-Holland, pp 607–608

    Google Scholar 

  13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680–685

    Google Scholar 

  14. Lin Y, Means GE, Feeny RE (1969) The action of proteolytic enzymes onN, N-dimethyl proteins: basis for a microassay for proteolytic enzymes. J Biol Chem 244:789–793

    PubMed  Google Scholar 

  15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  Google Scholar 

  16. Mattingly SJ, Milligan TW, Pierpont AA, Straus DC (1980) Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates. J Clin Microbiol 12:633–635

    PubMed  Google Scholar 

  17. Milligan TW, Baker CJ, Straus DC, Mattingly SJ (1978) Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun 21:738–746

    PubMed  Google Scholar 

  18. Milligan TW, Straus DC, Mattingly SJ (1977) Extracellular neuraminidase production by group B streptococci. Infect Immun 18:189–195

    PubMed  Google Scholar 

  19. Milligan TW, Mattingly SJ, Straus DC (1980) Purification and partial characterization of neuraminidase from type III group B streptococci. J Bacteriol 144:164–172

    PubMed  Google Scholar 

  20. Rinderknecht H, Geokas MC, Silverman P, Haverback BJ (1968) A new ultrasensitive method for the determination of proteolytic activity. Clin Chem Acta 21:197–203

    Google Scholar 

  21. Straus DC (1983) Protease production byStreptococcus sanguis associated with subacute bacterial endocarditis. Infect Immun 38:1037–1045

    Google Scholar 

  22. Straus DC, Mattingly SJ, Milligan TW, Doran TI, Nealon TJ (1980) Protease production by clinical isolates of type III group B streptococci. J Clin Microbiol 12:421–425

    PubMed  Google Scholar 

  23. Straus DC, Portnoy-Duran C (1983) Neuraminidase production by aStreptococcus sanguis strain associated with subacute bacterial endocarditis. Infect Immun 41:507–515

    PubMed  Google Scholar 

  24. Straus DC, Yeung MK, Durham DL, Mattingly SJ (1982) Lack of virulence of bovine type IIIStreptococcus agalactiae strains for mice correlates with reduced in vitro production of extracellular type specific antigen. Curr Microbiol 7:251–256

    Google Scholar 

  25. Terleckyj B, Willet NP, Shockman GD (1975) Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun 11:649–655

    PubMed  Google Scholar 

  26. Todd EW (1934) A comparative serological study of streptolysins derived from human and from animal infections with notes on pneumococcal hemolysin, tetanolysin, and staphylococcus toxin. J Pathol Bacteriol 39:299–321

    Google Scholar 

  27. Toennies G, Gallant DL (1949) The relationship between photometric turbidity and bacterial concentration. Growth 13:7–20

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Straus, D.C., Brown, J.G. Characterization of protease production by a type-III group-BStreptococcus . Current Microbiology 12, 127–134 (1985). https://doi.org/10.1007/BF01567664

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01567664

Keywords

Navigation